Anticipate several treatments and slower results compared to surgery
While at home, stick to a strict injection schedule
Immunity/inflammation and metabolism in PAIS Most symptoms of a PAIS are shared with other PAIS Table 1 summarizes the symptoms most frequently reported in long COVID, ME/CFS and long Lyme/PTLDS
Retatrutide, if approved in future, would represent a potential addition to this landscape but that determination rests on the outcome of ongoing phase 3 research and subsequent regulatory review by the MHRA and EMA
Compare this to typical Ponte Vedra pricing of $3,000-$7,200+ annuallyyou're saving $1,800-$4,800 per year while receiving the same quality care
Circulation 142(17):e265e286 American Diabetes Association Professional Practice Committee (2024) 10